<DOC>
	<DOCNO>NCT00828178</DOCNO>
	<brief_summary>The investigator hypothesize low-dose dietary supplementation omega-3 fish oil improve disease activity endothelial function Systemic Lupus Erythematosus ( SLE ) patient .</brief_summary>
	<brief_title>Efficacy Fish Oil Lupus Patients</brief_title>
	<detailed_description>Patients SLE fifty-fold increase risk myocardial infarction . This risk totally explain traditional cardiovascular risk factor . In previous double-blind study atorvastatin SLE , reduction surrogate measure coronary artery disease ( coronary calcium , coronary IMT , carotid plaque ) effect inflammatory marker ICAM , VCAM , IL-6 CRP . We need find novel approach reduce coronary artery disease SLE . In preliminary study , omega-3 show improve flow mediate dilation brachial artery , oxidative stress disease activity lupus patient . In study determine omega-3 improves brachial artery flow dilation , disease activity vascular inflammatory marker ( IL-6 , s-VCAM-1 , s-ICAM-1 ) SLE , double-blind placebo-controlled trial .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Patients clinical diagnosis SLE eligible . Patients must 18 year age old able give inform consent . SLE patient allergic fish oil omega 3 product . Patients pregnant plan become pregnant nursing . Omega3 use within previous 6 week enrollment . Use warfarin heparin . Patients coronary artery disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>SLE</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>omega-3</keyword>
</DOC>